Latest Lipid Therapeutics GmbH Stories
Lipid Therapeutics' European Partner Dr. Falk Pharma GmbH Enrolls First Patients Into Pivotal Phase III Trial With LT-02, a Novel Therapy for Ulcerative Colitis (UC)
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
Word of the Day
- Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.